Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
ACR 2018
okt 2018
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE